GT
SRRA

Glenmede Trust’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Glenmede Trust’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,889
Closed -$213K – 1409
2022
Q2 		$213K Buy
+3,889
New +$204K ﹤0.01% 1090

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Glenmede Trust's SRRA Position: Q3 2022 in Review

Glenmede Trust sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 3,889 shares — an estimated $213K sold.

Glenmede Trust first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $213K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Glenmede Trust reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Glenmede Trust sold 3,889 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $213K.
  • Glenmede Trust first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Glenmede Trust's Sierra Oncology, Inc. Common Stock position peaked at $213K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Glenmede Trust's 13F filing for Q3 2022, filed 16 Nov 2022.